BURLINGTON, Mass.–(BUSINESS WIRE)–PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446) today announced it will be presenting one oral presentation, nine posters, and five online publications at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12-15 in New Orleans, Louisiana. Following the recent FDA approval of BESREMi® (ropeginterferon alfa-2b-njft) for adults with essential thrombocythemia (ET), its second approved indica
